FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claude Vigneron

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Marie Hacquard; Julien Perrin; Nicolas Lelievre; Claude Vigneron; Thomas Lecompte
Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
Julien Perrin; Lise Morlon; Claude Vigneron; Monique Marchand-Arvier
Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM).
Younes SMANI; Pierre Labrude; Claude Vigneron; Béatrice Faivre
[Hemoglobin-based oxygen carriers and trials to substitute red blood cells].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claude Vigneron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Marie Hacquard; Julien Perrin; Nicolas Lelievre; Claude Vigneron; Thomas Lecompte
Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
Thrombosis research 2011;127(1):29-34.
2008: Julien Perrin; Lise Morlon; Claude Vigneron; Monique Marchand-Arvier
Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM).
Thrombosis research 2008;121(5):647-52.
2007: Younes SMANI; Pierre Labrude; Claude Vigneron; Béatrice Faivre
[Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2007;14(5):464-73.
2007: Valérie Hoffart; Philippe Maincent; Alf Lamprecht; Véronique Latger-Cannard; Veronique Regnault; Christian Merle; Jouan Hureaux Valerie; Thomas Lecompte; Claude Vigneron; Nathalie Ubrich
Immunoadsorption of alloantibodies onto erythroid membrane antigens encapsulated into polymeric microparticles.
Pharmaceutical research 2007;24(11):2055-62.
2007: J Perrin; A Perrot; V Chenot; Jean-François Lesesve; A Guerci; Monique Marchand-Arvier; Claude Vigneron; Thomas Lecompte
[Acquired alpha-thalassemia as early sign for myelodysplastic syndrome (refractory anaemia) with secondary haemochromatosis].
Annales de biologie clinique 2007;65(4):405-9.
2007: Marie Hacquard; M Angioï; Thomas Lecompte; Claude Vigneron
[Interindividual variability in the laboratory response to the aspirin-clopidogrel combination: are patients with stent occlusion "resistant" to treatment?].
Annales pharmaceutiques françaises 2007;65(3):169-73.
2007: Pascale Dewachter; Isabelle Raëth-Fries; Jouan Hureaux Valerie; Patrick Menu; Claude Vigneron; Dan Longrois; Paul-Michel Mertes
A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock.
Anesthesiology 2007;106(5):977-83.
2007: Claude Vigneron; Younes SMANI; Béatrice Faivre
[Blood substitutes: state of the art and technical setbacks and why we are still disappointed].
Bulletin de l'Académie nationale de médecine 2007;191(4-5):837-47; discussion 847.
2007: Younes SMANI; Alexandre Fifre; Pierre Labrude; Claude Vigneron; Béatrice Faivre
Pharmacological and physicochemical factors in the pressor effects of conjugated haemoglobin-based oxygen carriers in vivo.
Journal of hypertension 2007;25(3):599-608.
2006: J Perrin; Monique Marchand-Arvier; Véronique Latger-Cannard; Claude Vigneron; Thomas Lecompte
[Incubated osmotic fragility test does not exclude red blood cell membrane disorders! About a case of hereditary elliptocytosis].
Annales de biologie clinique 2006;64(5):491-5.
2006: Younes SMANI; Béatrice Faivre; I Fries; Pierre Labrude; Claude Vigneron
[Potential mechanism of dextran-conjugated hemoglobin penetration inside arterial wall].
Archives des maladies du coeur et des vaisseaux 2006;99(7-8):722-6.
2006: Valérie Hoffart; Alf Lamprecht; Philippe Maincent; Thomas Lecompte; Claude Vigneron; Nathalie Ubrich
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.
Journal of controlled release : official journal of the Controlled Release Society 2006;113(1):38-42.
2006: Alexis Caron; Marie Hacquard; Gérard Audibert; Ghislaine Cauchois; Claude Vigneron; Jean-François Stoltz; Dan Longrois; Patrick Menu
Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
Clinical hemorheology and microcirculation 2006;35(4):447-58.
2005: Younes SMANI; Béatrice Faivre; Sandra Audonnet-Blaise; Pierre Labrude; Claude Vigneron
[Relationship between arterial pressure evolution and free hemoglobin distribution into vascular wall in guinea pigs].
Archives des maladies du coeur et des vaisseaux 2005;98(7-8):821-4.
2005: Younes SMANI; Béatrice Faivre; Sandra Audonnet-Blaise; Pierre Labrude; Claude Vigneron
Hemoglobin-based oxygen carrier distribution inside vascular wall and arterial pressure evolution: is there a relationship?
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 2005;37(1):1-8.
2003: Anne Fohlen-Walter; Emmanuel de Maistre; Claude Vigneron; Thomas Lecompte; Jean-François Lesesve
[Risk of underestimating platelet count because of the increase of mean platelet volume at the end of pregnancy].
Annales de biologie clinique 2003;61(5):589-92.
2003: Marie Hacquard; Yvan Devaux; Dan Longrois; B Faivre-Fiorina; S Muller; Jean-François Stoltz; Claude Vigneron; Patrick Menu
Biological response of human aortic endothelial cells exposed to acellular hemoglobin solutions developed as potential blood substitutes.
Life sciences 2003;72(10):1143-57.
2003: Valérie Hoffart; Nathalie Ubrich; Alf Lamprecht; K Bachelier; Claude Vigneron; Thomas Lecompte; Maurice Hoffman; Philippe Maincent
Microencapsulation of low molecular weight heparin into polymeric particles designed with biodegradable and nonbiodegradable polycationic polymers.
Drug delivery 2003;10(1):1-7.
2003: Marie Toussaint; Véronique Latger-Cannard; Alexis Caron; Thomas Lecompte; Claude Vigneron; Patrick Menu
Hemoglobin-based oxygen carriers do not alter platelet functions: study of three chemically modified hemoglobin solutions.
Intensive care medicine 2003;29(1):62-8.
2002: Jean-François Bisson; Robert-Michel Parache; Pierre Droulle; Dominique Notter; Claude Vigneron; François Guillemin
A new method of implanting orthotopic rat bladder tumor for experimental therapies.
International journal of cancer. Journal international du cancer 2002;102(3):280-5.
2002: Valérie Hoffart; Nathalie Ubrich; C Simonin; V Babak; Claude Vigneron; Maurice Hoffman; Thomas Lecompte; Philippe Maincent
Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics.
Drug development and industrial pharmacy 2002;28(9):1091-9.
2002: Marianne Christophe; Jean-François Bisson; Dominique Notter; Robert-Michel Parache; Claude Vigneron; François Guillemin
Induction of syngeneic intradermal and orthotopic epidermal carcinomas in hairless Skh-1 mice as a reproducible model for experiments.
Anticancer research 2002;22(5):2869-75.
2002: Jean-François Bisson; Marianne Christophe; Juan-José Padilla-Ybarra; Dominique Notter; Claude Vigneron; François Guillemin
Determination of the maximal tumor:normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ.
Anti-cancer drugs 2002;13(8):851-7.
2002: Y Y Jiao; Nathalie Ubrich; Valérie Hoffart; Monique Marchand-Arvier; Claude Vigneron; Maurice Hoffman; Philippe Maincent
Preparation and characterization of heparin-loaded polymeric microparticles.
Drug development and industrial pharmacy 2002;28(8):1033-41.
2002: A Maurice; Monique Marchand-Arvier; D Edert; Alain Le Faou; G Gondrexon; Claude Vigneron
The virucidal effect of platelet concentrates: preliminary study and first conclusions.
Platelets 2002;13(4):219-22.
2002: Yuyan Jiao; Nathalie Ubrich; Valérie Hoffart; Monique Marchand-Arvier; Claude Vigneron; Maurice Hoffman; Philippe Maincent
Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits.
Journal of pharmaceutical sciences 2002;91(3):760-8.
2002: Véronique Latger-Cannard; Monique Marchand-Arvier; Michel Vidailhet; jean donadieu; Claude Vigneron; Pierre Bordigoni
Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.
European journal of pediatrics 2002;161(2):87-93.
2002: Yuyan Jiao; Nathalie Ubrich; Monique Marchand-Arvier; Claude Vigneron; Maurice Hoffman; Thomas Lecompte; Philippe Maincent
In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits.
Circulation 2002;105(2):230-5.
2001: Alexis Caron; J C Mayer; Patrick Menu; Abdu I Alayash; Pierre-Yves Marie; Claude Vigneron
Measurement of blood volume after haemodilution with haemoglobin-based oxygen carriers by a radiolabelled-albumin method.
Transfusion medicine (Oxford, England) 2001;11(6):433-42.
2001: François Guillemin; I Cosserat-Gérardin; Dominique Notter; Claude Vigneron
[Diagnosis and treatment of bladder tumors by photodynamic therapy].
Pathologie-biologie 2001;49(10):815-23.
2001: Y Y Jiao; Nathalie Ubrich; Monique Marchand-Arvier; Claude Vigneron; Maurice Hoffman; Philippe Maincent
Preparation and in vitro evaluation of heparin-loaded polymeric nanoparticles.
Drug delivery 2001;8(3):135-41.
2001: M Toussaint; Véronique Latger-Cannard; Alexis Caron; Thomas Lecompte; Jean-François Stoltz; Claude Vigneron; Patrick Menu
Effects of three Hb-based oxygen-carrying solutions on neutrophil activation in vitro: quantitative measurement of the expression of adherence receptors.
Transfusion 2001;41(2):226-31.
2001: MF Zambaux; Fr Bonneaux; Ruxandra Gref; Edith Dellacherie; Claude Vigneron
Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles.
International journal of pharmaceutics 2001;212(1):1-9.
2000: I Cosserat-Gerardin; Lina Bezdetnaya; Dominique Notter; Claude Vigneron; François Guillemin
Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells.
Journal of photochemistry and photobiology. B, Biology 2000;59(1-3):72-9.
2000: Alexis Caron; Patrick Menu; B Faivre-Fiorina; Pierre Labrude; Abdu I Alayash; Claude Vigneron
Systemic and renal hemodynamics after moderate hemodilution with HbOCs in anesthetized rabbits.
American journal of physiology. Heart and circulatory physiology 2000;278(6):H1974-83.
2000: MF Zambaux; B Faivre-Fiorina; F Bonneau; Sophie Marchal; Jean-Louis Merlin; Edith Dellacherie; Pierre Labrude; Claude Vigneron
Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig.
Biomaterials 2000;21(10):975-80.
2000: E Bossu; J J Padilla-Ybarra; Dominique Notter; Claude Vigneron; François Guillemin
Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.
Anti-cancer drugs 2000;11(2):85-91.
1999: David Chognot; MF Zambaux; Fr Bonneaux; Pascale Gaussem; J L Pittet; M Aiach; Claude Vigneron
Identification of protein C epitopes altered during its nanoencapsulation.
Journal of protein chemistry 1999;18(7):779-84.
1999: MF Zambaux; Fr Bonneaux; Ruxandra Gref; Edith Dellacherie; Claude Vigneron
Preparation and characterization of protein C-loaded PLA nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 1999;60(2-3):179-88.
1999: E Bossu; J J Padilla; O A'Amar; Robert-Michel Parache; Dominique Notter; Claude Vigneron; François Guillemin
Determination of endogenous porphyrins and the maximal HpD tumor/normal skin ratio in SKH-1 hairless mice by light induced fluorescence spectroscopy.
Artificial cells, blood substitutes, and immobilization biotechnology 1999;27(2):109-17.
1999: Patrick Menu; Dan Longrois; Béatrice Faivre; M Donner; Pierre Labrude; J F Stoltz; Claude Vigneron
Rheological behaviour of red blood cells suspended in hemoglobin solutions. In vitro study comparing dextran-benzene-tetra-carboxylate hemoglobin, stroma free hemoglobin and plasma expanders.
Transfusion science 1999;20(1):5-16.
1999: B Faivre-Fiorina; Alexis Caron; C Fassot; I Fries; Patrick Menu; Pierre Labrude; Claude Vigneron
Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs.
The American journal of physiology 1999;276(2 Pt 2):H766-70.
1999: Alexis Caron; Patrick Menu; B Faivre-Fiorina; Pierre Labrude; Abdu I Alayash; Claude Vigneron
Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;86(2):541-8.
1999: MF Zambaux; Fr Bonneaux; Ruxandra Gref; Edith Dellacherie; Claude Vigneron
MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties.
Journal of biomedical materials research 1999;44(1):109-15.
1999: Jean-François Bisson; Dominique Notter; Pierre Labrude; Claude Vigneron; François Guillemin
Induction of superficial bladder tumors in the female Fischer 344 rats with AY-27 tumor cells for the study of diffusion and localization of hemoglobin derived components (hematoporphyrin derivative) in view of photochemotherapy.
Artificial cells, blood substitutes, and immobilization biotechnology 1999;27(1):77-84.
1999: Alexis Caron; Patrick Menu; B Faivre-Fiorina; Pierre Labrude; Claude Vigneron
The effects of stroma-free and dextran-conjugated hemoglobin on hemodynamics and carotid blood flow in hemorrhaged guinea pigs.
Artificial cells, blood substitutes, and immobilization biotechnology 1999;27(1):49-64.
1998: B Faivre-Fiorina; Alexis Caron; Pierre Labrude; Claude Vigneron
[Erythrocyte, plasma and substitute hemoglobins facing physiological oxidizing and reducing agents].
Annales de biologie clinique 1998;56(5):545-56.
1998: Nathalie Ubrich; C Rivat; Claude Vigneron; Philippe Maincent
Microporous microparticles designed as stable immunoadsorbents.
Biotechnology and bioengineering 1998;58(6):581-6.
1998: Alexis Caron; Patrick Menu; Pierre Labrude; Claude Vigneron
Proposition of a technique to assess the vasoactive effects of hemoglobin-based oxygen carrying solutions in vivo: preliminary results in the rabbit aorta.
Artificial cells, blood substitutes, and immobilization biotechnology 1998;26(3):293-308.
1998: MF Zambaux; Fr Bonneaux; Ruxandra Gref; Philippe Maincent; Edith Dellacherie; M J Alonso; Pierre Labrude; Claude Vigneron
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
Journal of controlled release : official journal of the Controlled Release Society 1998;50(1-3):31-40.
1998: L Million; C Pellerin; Monique Marchand-Arvier; Claude Vigneron
A stable reagent system for screening and identifying red blood cell irregular antibodies: application to commercial antibodies.
Vox sanguinis 1998;75(4):288-97.
1998: Béatrice Faivre; Patrick Menu; Pierre Labrude; Claude Vigneron
Hemoglobin autooxidation/oxidation mechanisms and methemoglobin prevention or reduction processes in the bloodstream. Literature review and outline of autooxidation reaction.
Artificial cells, blood substitutes, and immobilization biotechnology 1998;26(1):17-26.
1997: Nathalie Ubrich; J Ngondi; C Rivat; M Pfister; Claude Vigneron; Philippe Maincent
Selective in vitro removal of anti-A antibodies by adsorption on encapsulated erythrocyte-ghosts.
Journal of biomedical materials research 1997;37(2):155-60.
1997: C Pellerin-Mendes; L Million; Monique Marchand-Arvier; Pierre Labrude; Claude Vigneron
In vitro study of the protective effect of trehalose and dextran during freezing of human red blood cells in liquid nitrogen.
Cryobiology 1997;35(2):173-86.
1997: E Bossu; O A'Amar; Robert-Michel Parache; Dominique Notter; Pierre Labrude; Claude Vigneron; François Guillemin
Determination of the maximal tumor/normal skin ratio after HpD or m-THPC administration in hairless mouse (SKh-1) by fluorescence spectroscopy--a non-invasive method.
Anti-cancer drugs 1997;8(1):67-72.
1996: Fr Bonneaux; Edith Dellacherie; Pierre Labrude; Claude Vigneron
Hemoglobin-dialdehyde dextran conjugates: improvement of their oxygen-binding properties with anionic groups.
Journal of protein chemistry 1996;15(5):461-5.
1995: Alexis Caron; Patrick Menu; Béatrice Faivre; Pierre Labrude; Claude Vigneron
[Pulsed Doppler ultrasonography to measure the vasoactive effects of hemoglobin-dextran 10-benzene-tetracarboxylate, a potential erythrocyte substitute].
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1995;2(6):453-62.
1995: F Ruspini; N Petitpain; Monique Marchand-Arvier; Claude Vigneron; C Janot
Blood group antigen survival on freeze-dried erythrocytes and ghosts after isolation.
Vox sanguinis 1995;68(2):105-8.
1995: Béatrice Faivre; V Labaeye; Patrick Menu; Pierre Labrude; Claude Vigneron
Assessment of dextran 10-benzene-tetracarboxylate-hemoglobin, an oxygen carrier, using guinea pig isolated bowel model.
Artificial cells, blood substitutes, and immobilization biotechnology 1995;23(4):495-504.
1995: Béatrice Faivre; Patrick Menu; Pierre Labrude; Claude Vigneron
[Evaluation of hemoglobin dextran 10-benzene-tetracarboxylate, oxygen transporters, using a model of guinea pig intestine].
Annales pharmaceutiques françaises 1995;53(3):111-8.
1995: Patrick Menu; M Donner; Béatrice Faivre; Pierre Labrude; Claude Vigneron
In vitro effect of dextran-benzene-tetra-carboxylate hemoglobin on human blood rheological properties.
Artificial cells, blood substitutes, and immobilization biotechnology 1995;23(3):319-30.
1994: N Cedrati; Philippe Maincent; F Thomas; Pierre Labrude; Claude Vigneron
Preparation and characterisation of poly(lactic acid) hemoglobin microspheres.
Artificial cells, blood substitutes, and immobilization biotechnology 1994;22(3):867-73.
1994: Béatrice Faivre; Patrick Menu; Pierre Labrude; M Grandgeorge; Claude Vigneron
Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin.
Artificial cells, blood substitutes, and immobilization biotechnology 1994;22(3):551-8.
1994: Patrick Menu; Béatrice Faivre; Pierre Labrude; P Riffard; M Grandgeorge; Claude Vigneron
Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II--Pharmacotoxicological evaluation.
Artificial cells, blood substitutes, and immobilization biotechnology 1994;22(3):543-9.
1993: A Morin; M M Arvier; J C Humbert; F Doutremepuich; Claude Vigneron
Influence of heparin on the chemotactic activity of human thrombin.
The Journal of pharmacy and pharmacology 1993;45(11):1009-11.
1993: Claude Vigneron
[Extracted hemoglobins as oxygen transporters: proposal of a hemoglobin-dextran-benzenetetracarboxylate conjugate].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1993;36(1):11-8.
1992: G Fasan; Claude Vigneron; Edith Dellacherie; M Grandgeorge
Large scale preparation of functional human placental hemoglobin for use in blood substitutes.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):489-91.
1992: Patrick Menu; Béatrice Faivre; Pierre Labrude; M Grandgeorge; Claude Vigneron
Possible importance of chromatographic purification position in a blood substitute elaboration process.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):443-5.
1992: P Mouelle; Patrick Menu; Pierre Labrude; M Grandgeorge; Claude Vigneron
A potential blood substitute from carboxylic dextran and oxyhemoglobin. III. Evaluations by perfusion of normal and ischemic guinea-pig heart.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):697-701.
1992: Béatrice Faivre; Patrick Menu; Pierre Labrude; M Grandgeorge; Claude Vigneron; Edith Dellacherie
A potential blood substitute from carboxylic dextran and oxyhemoglobin. II. Physicochemical and physiological assessments. Preliminary results on guinea pig.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):597-600.
1992: F Prouchayret; G Fasan; M Grandgeorge; Claude Vigneron; Patrick Menu; Edith Dellacherie
A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):319-22.
1991: Patrick Menu; P Mouelle; Y Clerc; Pierre Labrude; Claude Vigneron
Physico-chemical and pharmacological comparison of pyridoxylated hemoglobin bound to polyoxyethylene or polymerized by glutaraldehyde.
The International journal of artificial organs 1991;14(12):805-9.
1991: L Verstraeten; Monique Marchand-Arvier; F Schooneman; Claude Vigneron
Liquid preservation of polymorphonuclear leukocytes: effect of various additives on chemotaxis preservation.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1991;29(11):717-24.
1991: Patrick Menu; Pierre Labrude; M Grandgeorge; Claude Vigneron
Importance of purification on transfusional efficacy of hemoglobin solutions.
The International journal of artificial organs 1991;14(10):672-5.
1991: G Fasan; M Grandgeorge; Claude Vigneron; Edith Dellacherie
Preparation of unaltered hemoglobin from human placentas for possible use in blood substitutes.
Journal of biochemical and biophysical methods 1991;23(1):53-66.
1991: L Verstraeten; Monique Marchand-Arvier; F Schooneman; Claude Vigneron
[Storage of granulocytes].
Annales de biologie clinique 1991;49(3):161-5.
1991: L Verstraeten; Monique Marchand-Arvier; F Schooneman; Claude Vigneron
[Experimental study of a model for granulocyte storage].
Annales de biologie clinique 1991;49(3):155-60.
1991: A Morin; Monique Marchand-Arvier; C Doutremepuich; Claude Vigneron
Effect of hirudin on the chemotactic properties of alpha-thrombin.
Haemostasis 1991;21 Suppl 1():32-5.
1991: L Verstraeten; Monique Marchand-Arvier; F Schooneman; Claude Vigneron
[Chemotaxis of polynuclear neutrophils during a four-day storage in a liquid medium].
Annales de biologie clinique 1991;49(10):520-1.
1991: P Menu; C Geschier; Claude Vigneron; Pierre Labrude
Does Tris-HCl effectively participate in transamination during hemoglobin pyridoxylation?
Biomedica biochimica acta 1991;50(8):981-6.
1991: Béatrice Faivre; Pierre Labrude; Claude Vigneron
Assessment of histocompatibility of different hemoglobin solutions using mesenteric perfusion on the small bowel of the male Wistar rat.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1991;19(3):521-37.
1990: A Morin; M M Arvier; F Doutremepuich; Claude Vigneron
Localization of the structural domain responsible for the chemotactic properties of thrombin on polymorphonuclear leukocytes.
Thrombosis research 1990;60(1):33-42.
1990: Claude Vigneron
[Artificial blood in 1990: from a lifelong dream to today's reality].
Bulletin de l'Académie nationale de médecine 1990;174(7):947-57; discussion 957-8.
1990: A Morin; M M Arvier; F Doutremepuich; Claude Vigneron
Coagulation impact on chemotactic activity generation for polymorphonuclear leukocytes.
Thrombosis research 1990;59(6):979-84.
1990: P Menu; Pierre Labrude; Claude Vigneron
Usual physicochemical criteria provide insufficient evidence that a functional hemoglobin solution can be used for transfusions after storage for 36 months at +4 degrees C.
Biomaterials, artificial cells, and artificial organs 1990;18(2):169-81.
1990: P Menu; C Geschier; Pierre Labrude; Claude Vigneron
Haemoglobin pyridoxalation in phosphate buffer: comparison of results with those obtained with Tris-HCl buffer.
Biomaterials, artificial cells, and artificial organs 1990;18(2):157-68.
1990: P Moser; Monique Marchand-Arvier; Pierre Labrude; Claude Vigneron
[Hemoglobin niosomes. II. In vitro interactions of plasma proteins and phagocytes].
Pharmaceutica acta Helvetiae 1990;65(3):82-92.
1989: Pierre Labrude; M Rasolomanana; Claude Vigneron; C Thirion; B Chaillot
Protective effect of sucrose on spray drying of oxyhemoglobin.
Journal of pharmaceutical sciences 1989;78(3):223-9.
1989: P Moser; Monique Marchand-Arvier; Pierre Labrude; R M Handjani-Vila; Claude Vigneron
[Hemoglobin niosomes. I. Preparation, functional and physico-chemical properties, and stability].
Pharmaceutica acta Helvetiae 1989;64(7):192-202.
1988: N Berradia; Monique Marchand-Arvier; J C Humbert; Claude Vigneron
Effects of indomethacin and diclofenac on some functions of polymorphonuclear neutrophils.
The Journal of pharmacy and pharmacology 1988;40(11):806-8.
1988: Pierre Labrude; P Mouelle; Patrick Menu; Claude Vigneron; Edith Dellacherie; M Leonard; J L Tayot
Hemoglobin solutions coupled with polyethylene glycol 1900: preparation, purification, quality control and pharmacological trials by hemorrhagic shock.
The International journal of artificial organs 1988;11(5):393-402.
1987: P Menu; F Pauly; P Labrude; Claude Vigneron
Haemoglobin pyridoxylation: optimization and observation of an additional new pyridoxal phosphate-haemoglobin species by high-performance liquid chromatographic resolution.
Journal of chromatography 1987;417(2):397-402.
1987: Pierre Labrude; B Chaillot; Claude Vigneron
Problems of haemoglobin freeze-drying: evidence that water removal is the key to iron oxidation.
The Journal of pharmacy and pharmacology 1987;39(5):344-8.
1986: Monique Marchand-Arvier; P Brucker; Claude Vigneron
[Influence of Intralipid on the properties of circulating phagocytes].
Presse médicale (Paris, France : 1983) 1986;15(2):65-7.
1985: Claude Vigneron; Monique Marchand-Arvier
[Isoenzymes of blast cells in malignant hemopathies: present state and prospectives].
Annales de biologie clinique 1985;43(2):117-25.
1984: Pierre Labrude; B Chaillot; Claude Vigneron
Influence of physical conditions on the oxidation of hemoglobin during freeze-drying.
Cryobiology 1984;21(1):33-8.
1983: Edith Dellacherie; Fr Bonneaux; Pierre Labrude; Claude Vigneron
Modification of human hemoglobin by covalent association with soluble dextran.
Biochimica et biophysica acta 1983;749(1):106-14.
1983: C Thirion; D Larcher; B Chaillot; Pierre Labrude; Claude Vigneron
Circular dichroism studies of freeze-drying-induced conformational changes in human hemoglobin.
Biopolymers 1983;22(11):2367-81.
1983: Monique Marchand-Arvier; Claude Vigneron
[Rapid isolation of human monocytes on a density gradient of Lymphoprep followed by Percoll, for the purpose of functional study].
Annales de biologie clinique 1983;41(3):221-2.
1981: B Chaillot; Pierre Labrude; Claude Vigneron; D Simatos
Freeze-drying of hemoglobin solutions without adjuvant and in presence of glucose, tris, and beta-alanine: a study by electron spin resonance of the oxidized compounds produced.
American journal of hematology 1981;10(4):319-26.
1981: Pierre Labrude; Fr Bonneaux; Claude Vigneron
An attempt to freeze-dry haemoglobin in the presence of macromolecules.
The Journal of pharmacy and pharmacology 1981;33(2):115-7.
1980: Pierre Labrude; B Chaillot; Fr Bonneaux; Claude Vigneron
Freeze-drying of haemoglobin in the presence of carbohydrates.
The Journal of pharmacy and pharmacology 1980;32(8):588-9.